Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Case Studies: Lung Cancer
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
A Chemoimmunotherapeutic Approach to Nondriver NSCLC
Considering Triplet Therapy for Nondriver NSCLC
Managing Metastatic NSCLC With Rapid Progression
Clinical Management of NSCLC With Bone Metastases
Treatment Regimen for Patients With ALK+ Non-Small Cell Lung Cancer
A 50-Year-Old Woman With ALK-Rearranged NSCLC
Considerations for Treating Locally Advanced NSCLC
Consolidation Therapy for Locally Advanced NSCLC
Treatment Considerations for Unresectable Locally Advanced NSCLC
Frontline Treatment Strategies in EGFR-Mutant NSCLC
Clinical Approach for Unresectable Locally Advanced NSCLC
EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases
EGFR+ NSCLC
Non-Driver NSCLC: Practice Considerations
Clinical Decisions in Non-Driver NSCLC
Treatment of NSCLC With Uncommon EGFR Mutations
NonDriver Metastatic Lung Large Cell Carcinoma
A Case of Metastatic ALK-Rearranged Non-Small Cell Lung Cancer
ALK-Translocated Non-Small Cell Lung Cancer With Bone Metastases
Treatment of BRAF Mutated Non-Small Cell Lung Cancer
Treatment of ALK+ Non-Small Cell Lung Cancer
Treatment of EGFR Mutant Non-Small Cell Lung Cancer
NSCLC with Multiple Sites of Metastasis and No Driver Mutation
Metastatic Lung Adenocarcinoma Without a Driver Mutation
Advanced Squamous Non-Small Cell Lung Cancer
Nuances in Treating Squamous Cell Lung Cancer
Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD
EGFR Testing for Metastatic Non-Small Cell Lung Cancer with Jonathan W. Riess, MD, MS
Metastatic Lung Cancer with Jared M. Weiss, MD
mNSCLC with Mark Kris, MD and Mark Socinski, MD
Molecular Diagnostics in NSCLC with David Berz, MD, PhD, and Philip Bonomi, MD
Metastatic NSCLC with Corey J. Langer, MD, David Spigel, MD, Denise O'Dea, NP, and Jack West, MD
JTT Articles
The Role of Liquid Biopsy in NSCLC Continues to Emerge
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
Researchers Look to CAR T-Cell Therapy as Immunotherapy Outcomes Diminish in Glioblastoma
>> View Peer-Reviewed Articles
Most Popular
Key Takeaway Points in Phase III ALCYONE Trial for Multiple Myeloma
Finasteride Effective in Preventing Prostate Cancer
Lenalidomide Maintenance Improves PFS, OS in Patients With Transplant-Eligible Multiple Myeloma
Enzalutamide Leads to Extended Radiographic PFS in Metastatic Hormone-Sensitive Prostate Cancer
Publications